Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-[3-(3,4-dichlorobenzylamino)-1-hydroxymethylpropylamino]-1H-quinolin-4-one | - |
Staphylococcus aureus | |
2-[3-(3,4-dichlorobenzylamino)-2-hydroxypropylamino]-1H-quinolin-4-one | - |
Staphylococcus aureus | |
2-[3-(3,4-dichlorobenzylamino)-2-methoxypropylamino]-1H-quinolin-4-one | - |
Staphylococcus aureus | |
2-[3-(3,4-dichlorobenzylamino)-4-hydroxybutylamino]-1H-quinolin-4-one | - |
Staphylococcus aureus | |
2-[3-(3,4-dichlorobenzylamino)-propylamino]-1H-quinolin-4-one | - |
Staphylococcus aureus | |
4-[3-(3,4-dichlorobenzylamino)propylamino]-1H-quinolin-2-one | - |
Staphylococcus aureus | |
additional information | in vitro minimum inhibitory concentrations of quinoline compounds with different strains of Staphylococcus aureus, structure-activity relationships | Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
methionyl-tRNA synthetase | - |
Staphylococcus aureus |
MRS | - |
Staphylococcus aureus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000011 | - |
isozyme MRSA | Staphylococcus aureus | 2-[3-(3,4-dichlorobenzylamino)-propylamino]-1H-quinolin-4-one | |
0.0000023 | - |
- |
Staphylococcus aureus | 2-[3-(3,4-dichlorobenzylamino)-2-hydroxypropylamino]-1H-quinolin-4-one | |
0.0000025 | - |
- |
Staphylococcus aureus | 2-[3-(3,4-dichlorobenzylamino)-2-methoxypropylamino]-1H-quinolin-4-one | |
0.0000029 | - |
- |
Staphylococcus aureus | 2-[3-(3,4-dichlorobenzylamino)-4-hydroxybutylamino]-1H-quinolin-4-one | |
0.0000186 | - |
- |
Staphylococcus aureus | 2-[3-(3,4-dichlorobenzylamino)-1-hydroxymethylpropylamino]-1H-quinolin-4-one | |
0.00495 | - |
- |
Staphylococcus aureus | 4-[3-(3,4-dichlorobenzylamino)propylamino]-1H-quinolin-2-one |